Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 668 to 717 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
668\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ABLIM1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
actin-binding lim protein 1 isoform a; lim actin-binding protein 1; limatin; actin-binding lim protein. [source:refseq;acc:nm\_002313]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
669\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SYN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
synapsin i (brain protein 4.1). [source:swissprot;acc:p17600]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
670\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
autoantigen ngp-1. [source:swissprot;acc:q13823]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.302\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.817\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
671\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleotide-binding protein 1 (nbp 1). [source:swissprot;acc:p53384]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
210.739\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
199.398\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05688\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
672\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUBP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleotide binding protein 2 (nbp 2). [source:swissprot;acc:q9y5y2]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
673\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CASK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.497\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.355\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05664\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
674\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIF3A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
675\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIM1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
676\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLR2G\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 19 kda polypeptide (ec 2.7.7.6) (rpb7). [source:swissprot;acc:p52433]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
245.613\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05654\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LSM4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm4 (glycine-rich protein) (grp). [source:swissprot;acc:q9y4z0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.944\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.745\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05628\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNX5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.175\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOXB4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOXC5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-c5 (hox-3d) (cp11). [source:swissprot;acc:q00444]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-c6 (hox-3c) (hho.c8) (cp25). [source:swissprot;acc:p09630]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOXD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-d4 (hox-4b) (hox-5.1) (hho.c13). [source:swissprot;acc:p09016]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOXB5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-b5 (hox-2a) (hho.c10) (hu-1). [source:swissprot;acc:p09067]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOXA5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-a5 (hox-1c). [source:swissprot;acc:p20719]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hox-a4 (hox-1d) (hox-1.4). [source:swissprot;acc:q00056]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HSD17B14\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
retinal short-chain dehydrogenase/reductase 3. [source:refseq;acc:nm\_016246]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLR2D\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 16 kda polypeptide (ec 2.7.7.6) (rpb4). [source:swissprot;acc:o15514]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
250.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05586\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TCP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
t-complex protein 1, alpha subunit (tcp-1-alpha) (cct-alpha). [source:swissprot;acc:p17987]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
135.379\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
128.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05579\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNW1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.593\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.987\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BCAS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.602\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
206.195\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05532\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC5L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOVA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein nova-1 (neuro-oncological ventral antigen 1) (onconeural ventral antigen-1) (paraneoplastic ri antigen) (ventral neuron-specific protein 1). [source:swissprot;acc:p51513]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.847\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05524\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna polymerase epsilon, catalytic subunit a (ec 2.7.7.7) (dna polymerase ii subunit a). [source:swissprot;acc:q07864]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.907\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
229.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05475\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPIL4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.135\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.405\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05471\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SFRS18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sr rich protein. [source:refseq;acc:nm\_032870]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.293\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FTH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ferritin heavy chain (ferritin h subunit). [source:swissprot;acc:p02794]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.444\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.113\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05419\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FTMT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial ferritin; ferritin heavy chain-like; ferritin h subunit. [source:refseq;acc:nm\_177478]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.437\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.118\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05413\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CREG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes 2. [source:refseq;acc:nm\_153836]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.438\vspace{3pt}}}&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj681n20.2 (novel protein similar to ferritin, light polypeptide (ftl)). [source:sptrembl;acc:q9byw6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLGAP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
disks large-associated protein 1 (dap-1) (guanylate kinase-associated protein) (hgkap) (sap90/psd-95-associated protein 1) (sapap1) (psd- 95/sap90 binding protein 1). [source:swissprot;acc:o14490]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AHCYL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 2 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:o43865]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIAA0430\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
limkain b1. [source:refseq;acc:nm\_019081]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 3 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:q96hn2]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CREG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes. [source:refseq;acc:nm\_003851]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLGAP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
disks large-associated protein 3 (dap-3) (sap90/psd-95-associated protein 3) (sapap3) (psd-95/sap90 binding protein 3) (fragment). [source:swissprot;acc:o95886]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KNG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kininogen precursor (alpha-2-thiol proteinase inhibitor) [contains: bradykinin]. [source:swissprot;acc:p01042]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
708\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
disks large-associated protein 2 (dap-2) (sap90/psd-95-associated protein 2) (sapap2) (psd-95/sap90 binding protein 2) (fragment). [source:swissprot;acc:q9p1a6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
709\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FTL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ferritin light chain (ferritin l subunit). [source:swissprot;acc:p02792]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
710\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLGAP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
disks large-associated protein 4 (dap-4) (sap90/psd-95-associated protein 4) (sapap4) (psd-95/sap90 binding protein 4). [source:swissprot;acc:q9y2h0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tyrosyl-trna synthetase (ec 6.1.1.1) (tyrosyl--trna ligase) (tyrrs). [source:swissprot;acc:p54577]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.468\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
245.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05411\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
712\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FTHL17\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ferritin heavy polypeptide-like 17. [source:swissprot;acc:q9bxu8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.431\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.123\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05407\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF3M\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dendritic cell protein. [source:refseq;acc:nm\_006360]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.121\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
211.685\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05402\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPXM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potential carboxypeptidase-like protein x2 precursor. [source:swissprot;acc:q8n436]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase n catalytic chain precursor (ec 3.4.17.3) (arginine carboxypeptidase) (kininase 1) (serum carboxypeptidase n) (scpn) (anaphylatoxin inactivator) (plasma carboxypeptidase b). [source:swissprot;acc:p15169]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPZ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cpz gene product. [source:refseq;acc:nm\_003652]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/